Chancellor Rachel Reeves will announce a transformative £86 billion in the Spending Review to turbo-charge our fastest growing sectors, from tech and life sciences, to advanced manufacturing and defence, as part of the government’s plan to invest in Britain’s renewal through our Modern Industrial Strategy.
As the BIA Parliament Day marks its 25th year, 50 senior figures from the UK life sciences community are gathering in Westminster to urge bold government action to deliver much-needed growth for the UK economy.
The proposals outlined in the report are a major step towards realising BIA’s long-held goal of increasing investment from UK pension funds into UK life sciences.
Karen Johal, Senior Director at FTI Consulting LLP, explores how salary sacrifice for pensions offers a smart solution to rising employment costs - helping employers cut costs without cutting staff.
WHO members adopted the pandemic preparedness accord as an international treaty at the World Health Assembly. In this blog, Senior Policy and Public Affairs Manager Linda Bedenik looks at what the agreement means for life sciences.
The policy landscape for deep biotech has seen remarkable strides over the past year, positioning the UK as a leader in engineering biology innovation.
In this webinar, get a comprehensive overview of the UK’s biotech and life sciences presence at BIO 2025. Learn about the UK delegation’s plans, including the UK Pavilion organised by the Department for Business and Trade.
The Mansion House Accord fails to sparkle, but as the UK and EU reset relations, our focus turns to opportunities in deep biotech and the need for migration policy to support the talent our sector needs to thrive.
BIA has responded to the call for evidence, highlighting the urgent need to close the scale-up funding gap and calling for pension fund reform to keep innovation and economic growth in the UK.
In 2035, we envision a UK biotech sector with a stronger long-term capital base supporting both early—and later-stage firms. To make Vision 2035 a reality, we, as a sector, must focus on areas that will have the greatest impact. Read the report to find out what those are!
BIA publishes its 10-year Vision for the UK life science sector, the culmination of 18 months of research and engagement with members and the broader life science ecosystem.
We are calling on the UK government to mandate pension funds to invest in high-growth UK sectors, as new data from its latest report shows British pension schemes are still missing from the biggest biotech deals.
BIA has responded to the DBT's consultation on potential UK tariffs in response to US measures, urging to protect life sciences supply chains, innovation, and patient access.
Our response supported stronger HMRC powers to reduce fraud in the R&D tax relief system while protecting legitimate claims that drive innovation and economic growth.
This week saw the publication of Engineering Biology Aspirations, the final output of Angela McLean’s Year of Engineering Biology. The report sets out an ambitious, forward-looking vision for the field, exploring how engineering biology could shape the future of everything from food and fashion to fuel and health.
